The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Check out Kazera Global PLC on X.
https://x.com/KazeraGlobalInv
Kazera Global is a London Listed Fully Funded, Commodity Diverse Mining Investment Company. #Diamonds #HeavyMineralSands #KZG #AIM
And their finances must also be a major contributor to the drop. Not a pretty picture. Debt is high, and they need funds. However it does appear that instead of burying their head in the sand, the company is taking active steps to manage the situation to maintain the company as a going concern Read the K10 for the full breakdown.
NEXT-ChemX is down 80% over the last year, and Clontarf is down 70% in the same period.
Something had to be afoot. I had previously requested twice by email to NEXT-ChemX (info@next-chemx.com as published on their website) for updates to be published on the tech pilot plants progress in TX. Nada. Niente. Nichts. شيء . Not even an acknowledgement.
So I did some more digging around for news and came across their Annual Report to 31 Dec 2023(SEC K10 form filed on 1st April 2024) which makes for some very interesting reading. It certainly explains the significant drop in share price as plans and timelines have significantly changed.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1657045/000149315224012269/form10-k.htm
“The Company’s progress towards Market Readiness.
It is always difficult to identify exactly where any technology is to be found along the path to its commercialization and how soon it will be ready for commercial deployment. Throughout fiscal year 2023, the focus was on the design and construction of a controlled pilot system consistent with the needs of the pilot testing phase. In order better to concentrate on this, given the limited resources and knowing that the extraction technology has been proven in the laboratory for a variety of critical materials, the Illinois Laboratory was closed during 2023 and the Company turned to consider the engineering issues using consultants and contractors from India. having proven certain extraction rates, and the ability of the iTDE Technology to operate effectively. This puts us into the second phase. The best estimate for completion of the controlled pilot plant is that it will be operational at the beginning of the third quarter of 2024. If successful, this could lead to operational pilot deployment at customer sites in the first quarter of 2025.”
So there we have it. I wonder how that impacts pitching for the business in Bolivia? Maybe the fact that it has been shown to work in the lab, and that the financial qualification is apparently in place, is enough evidence for now for the Bolivians to keep them in the game.
I guess we will find out soon enough.
Https://ukinvestor.com/eight-golden-rules-for-using-bulletin-boards/
What an entertaining double act. Thank goodness this is just a bulletin board of anonymous posters and no sane investor would take any information supplied here seriously.
Https://x.com/BMWGroup/status/1776157842942079241
@BMWGroup·
Apr 7
Hydrogen doesn’t just represent a viable option for powering future cars, it is also a promising fuel source for transport logistics:
👉 allowing for fast refuelling and high payloads
👉 paving the way forward for lower-carbon, long-distance logistics
#BMWGroup #hydrogen
As a LTH I'm trying to be disciplined by not buying anymore having averaged down over time - the price here looks very attractive, and certianly all the pointers are to a rerate. Not sure about the market waking up to it as volume is still very low but it seems that news is imminent, so lets see what happens over the next month or so....
Loads of info on the internet. All you've got to do is put the question in to the search bar, instead of asking others to do the work for you. However, out of the goodness of my heart:
Re what happens (courtesy of Yahoo Finance):
- If the buyout is an all-cash deal, shares of your stock will disappear from your portfolio at some point following the deal's official closing date and be replaced by the cash value of the shares specified in the buyout.
- If it is an all-stock deal, the shares will be replaced by shares of the company doing the buying. It’s important to note that the ratio of old shares to new shares is rarely one-to-one.
- Some deals include a combination of cash and stock as well.
Re Value:
That depends on what the buyer wants to pay....
And take a look here too:
https://www.fool.co.uk/investing-basics/understanding-the-market/takeovers-and-mergers/
I did try and warn y’all:
TheBasher
Posted in: VAL
Posts: 714
Price: 5.00
No Opinion
RE: Scientific Advisory Board31 Jan 2024 04:12
@year1970
I completely agree. My post from 2nd Jan 24:
Posted in: VAL
Posts: 677
Price: 5.90
No Opinion
RE: THE YEAR OF THE PHOENIX ?
2 Jan 2024 00:44
Aka THE YEAR OF THE LEPER…
I’ve been in VAL for many years and still hold some shares to show it’s catastrophic loss in my portfolio - it serves as a clear and daily reminder to me not to repeat mistakes of the past.
On 16th Dec, the sp was 14p, and there were keyboard warriors claiming significant funds were coming in and that 20p, 30p, 40p and 50p or more was extremely likely. The sp is now at 5.9p. Says it all really and potential new investors should take note.
Below is what was posted by me 5 Nov 2023 and then on 16th Dec 2023 in response to all the bullish rumours on this board.:
TheBasher
Posted in: VAL
Posts: 651
Price: 14.125
No Opinion
Only 97% down. Tumbleweed moment with VAL 401!
I feel like I’ve been here before…
Oh, I have.
Time will tell if it’s any different to the 2nd, 3rd or however many false starts there have been.
Only need another 900%+ to recover my losses.
A leopard never changes its spots, neither does a leper (which is a pretty apt way of describing a chronically sick excuse of a pharma company).
@steven49
“management partly to blame”???
Re-read the RNS.
Absolutely damning statement from JW.
100% its management incompetence.
Quite astonishing what JW has uncovered including that the then production plans were uneconomic. Knowing what I know now, I would have sold all my holding, rather then just 50% last year to invest in Kodal.
All hopes for a recovery now rest on his shoulders, and his ability to secure funding and/or do a successful placing. He is motivated to do so as he, as he points out in the RNS, has a significant financial stake in the outcome. Good luck JW.
From what Dennis has said about structuring the company,, the purchase of 29.9% of the company, the change of registered office, there could be company-changing news on the way, perhaps even owner-changing news. I know as much as the next guy, but I’ve been trying to make sense of the shenanigans, and this seems to be the explanation that surfaces easily.